COMMUNIQUÉS West-GlobeNewswire

Design Therapeutics to Participate in 2025 Jefferies Global Healthcare Conference
28/05/2025
CARLSBAD, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that [...]
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
28/05/2025
NEW YORK and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly [...]
Yerbaé Joins TikTok Shop to Accelerate Growth and Expand Digital Reach
28/05/2025
SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc . (Nasdaq: SHOT) (“SHOT”, "Safety Shot”, or the “Company”), a wellness and dietary supplement company, announces its acquisition partner, Yerbaé [...]
ABLi Therapeutics Strengthens Leadership Team and Board of Directors
28/05/2025
Directors Appointed from Senior Leadership Teams of J&J and Atalanta Appointment of Chief Operating Officer Continues Building of Neuroscience Focused Team of Accomplished Professionals ATLANTA and BOSTON, May 28, [...]
Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference
28/05/2025
BOTHELL, Wash., May 28, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc . (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that management will participate in a fireside chat during the Noble Capital Markets’ 2025 [...]
Un avenir où la santé des femmes est une priorité : La Fondation du CUSM lance un mouvement de 5 M$ pour changer l’avenir des soins
28/05/2025
MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- Les femmes méritent des soins de santé pensés pour elles. Elles méritent de faire partie intégrante de la recherche, de recevoir des soins adaptés à leurs besoins et d’avoir [...]
A Future Where Women’s Health Leads: The MUHC Foundation Launches $5 Million Movement for Change
28/05/2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- Women deserve health care designed with them in mind. They deserve research that includes them, care that reflects their needs, and a future where their well-being is a top [...]
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
28/05/2025
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that [...]
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
28/05/2025
WEST CHESTER, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical [...]
Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates
28/05/2025
Issues nationwide nephrologist solicitation for patients for a 100-patient study involving kidney disease JACKSON CENTER, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC: HALB) in cooperation with Athena [...]
genXtraits Inc. expands collaboration with The New Zealand Institute for Plant & Food Research Limited to increase vitamin C in crops, including corn and soybean
28/05/2025
ALAMEDA, Calif. , May 28, 2025 (GLOBE NEWSWIRE) -- genXtraits Inc. (genXtraits) today announced that it has expanded its license and collaboration agreement with The New Zealand Institute for Plant and Food Research [...]
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
28/05/2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that [...]
Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method
28/05/2025
— Innovative approach accelerates new product development and testing — SILVER SPRING, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix [...]
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
28/05/2025
LAKEWOOD, Colo., May 28, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced [...]
4DMT to Participate in Upcoming Investor Conferences
28/05/2025
EMERYVILLE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
28/05/2025
NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]
SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy
28/05/2025
Coverage marks SeaStar Medical’s second award by CMS for reimbursement of medical expenses for Medicare and Medicaid patients in a clinical trial Stands out as rare award with less than 100 clinical trials covered [...]
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
28/05/2025
WEXFORD, Pa. and PRINCETON, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- SNAP Biosciences, Inc a majority-owned subsidiary of Coeptis Therapeutics Holdings Inc. (Nasdaq: COEP) and Monarch Therapeutics Inc., a biotechnology [...]
Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025
28/05/2025
New data finds novel cell therapy successfully converts “cold” ovarian tumors into “hot,” demonstrating potential to unlock immune response and improve outcomes CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Ernexa [...]

Pages